Length of Cook Catheter Placement and Induction of Labor

May 29, 2022 updated by: Sarah E Little, Brigham and Women's Hospital

Length of Cook Catheter Placement and Induction of Labor: a Randomized Controlled Trial

The goal of this study is to compare cook catheter placement for 6 vs. 12 hours to see if there is faster time to delivery for people admitted to labor and delivery undergoing induction of labor.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Upon presentation to labor and delivery the participant will have a cook catheter inserted digitally or by direct visualization with a speculum. The uterine component of the balloon will be inflated to maximum 60mL. The catheter will be taped to the inner thigh with gentle traction. In both groups participants will be started on hospital-based oxytocin protocol. This protocol beings with 2 milliunits/min of oxytocin, increasing by 2 milliunits every 15 minutes until regular uterine contractions occur. The maximum dose of oxytocin is considered to be 30 milliunits. The cook catheter will then be removed at 6 vs. 12 hours based on randomization. At that point health care providers will manage active labor. Health care providers many perform amniotomy at any point during the induction process with recommendation for amniotomy with cervix more than 4cm dilated. Labor interventions are at the discretion of the healthcare provider. The participants will have continuous fetal monitoring throughout their induction, labor and delivery. Need for operative delivery or cesarean section will be at the discretion of the health provider.

Study Type

Interventional

Enrollment (Actual)

178

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02116
        • Brigham and Women's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria: Women undergoing cervical ripening for labor induction at term (37-41 6/7 weeks) with a singleton gestation in cephalic presentation. Women will need to have a bishop score <6 or cervical dilation <2cm with intact membranes to be included.

Exclusion Criteria:

  • Non English speaking
  • Contraindications to vaginal delivery
  • Prior cesarean section

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 6 hour foley
The participant will have a cook catheter inserted digitally or by direct visualization with a speculum with the uterine component of the balloon inflated to maximum 60mL. The catheter will be taped to the inner thigh with gentle traction. Participants will be started on hospital-based oxytocin protocol. The cook catheter will then be removed at 6 hours, determined by randomization. At that point health care providers will manage active labor.
see arm description
No Intervention: 12 hour foley
The participant will have a cook catheter inserted digitally or by direct visualization with a speculum with the uterine component of the balloon inflated to maximum 60mL. The catheter will be taped to the inner thigh with gentle traction. Participants will be started on hospital-based oxytocin protocol. The cook catheter will then be removed at 12 hours, determined by randomization. At that point health care providers will manage active labor.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to Delivery
Time Frame: Assessed following delivery (delivery day, day 0)
Time to delivery
Assessed following delivery (delivery day, day 0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cesarean Delivery Rate
Time Frame: Assessed following delivery (delivery day, day 0)
Cesarean delivery rate
Assessed following delivery (delivery day, day 0)
Time to Active Labor
Time Frame: Assessed following delivery (delivery day, day 0)
Time to reaching active labor (defined as 5cm)
Assessed following delivery (delivery day, day 0)
Delivery Within 12 Hours
Time Frame: Assessed following delivery (delivery day, day 0)
The number of women in each group who deliver within 12 hours
Assessed following delivery (delivery day, day 0)
Delivery Within 24 Hours
Time Frame: Assessed following delivery (delivery day, day 0)
The number of women in each group who deliver within 24 hours
Assessed following delivery (delivery day, day 0)
Maternal Length of Stay
Time Frame: Assessed at end of study period (week 4)
Length of hospital stay from start of induction to postpartum discharge
Assessed at end of study period (week 4)
Indication for Cesarean Delivery
Time Frame: Assessed following delivery (delivery day, day 0)
Number of Patient with Indication for Cesarean Delivery
Assessed following delivery (delivery day, day 0)
Maternal Complications
Time Frame: Assessed at end of study period (week 4)
Estimated blood loss, blood transfusion, higher order laceration, endometritis, wound infection, venous thromboembolism, hysterectomy, ICU admission, maternal death
Assessed at end of study period (week 4)
Neonatal Complications
Time Frame: Assessed at end of study period (week 4)
culture-proven neonatal sepsis, neonatal blood transfusion, hypoxic-ischemic encephalopathy, intraventricular hemorrhage grade 3 or 4, or therapeutic hypothermia
Assessed at end of study period (week 4)
NICU Admission
Time Frame: Assessed at end of study period (week 4)
Number of infants admitted to NICU
Assessed at end of study period (week 4)
NICU Admission >48 Hours
Time Frame: Assessed at end of study period (week 4)
Number of infants admitted to NICU for >48 hours
Assessed at end of study period (week 4)
Neonatal Length of Stay
Time Frame: Assessed at end of study period (week 4)
Days of hospital stay
Assessed at end of study period (week 4)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sarah E Little, MD, Brigham and Women's Hospital, Harvard Medical School, Boston MA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

July 1, 2020

Study Completion (Actual)

July 1, 2020

Study Registration Dates

First Submitted

January 13, 2020

First Submitted That Met QC Criteria

January 15, 2020

First Posted (Actual)

January 18, 2020

Study Record Updates

Last Update Posted (Actual)

June 24, 2022

Last Update Submitted That Met QC Criteria

May 29, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 54321

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

Research only shared within study staff

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Induction of Labor

Clinical Trials on Foley catheter length

3
Subscribe